Scarica l'app Stockscreener
68.01
1.89%
-1.31
Dopo l'orario di chiusura:
67.76
-0.25
-0.37%
Precedente Chiudi:
$69.32
Aprire:
$68.89
Volume 24 ore:
149.10K
Relative Volume:
1.25
Capitalizzazione di mercato:
$229.97M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-4.25%
1M Prestazione:
-3.00%
6M Prestazione:
+22.17%
1 anno Prestazione:
+43.75%
Intervallo 1D:
$67.91
$69.06
Intervallo di 1 settimana:
$67.91
$71.13
Portata 52W:
$45.80
$74.34
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Company Profile
Nome
State Street Spdr S P Pharmaceuticals Etf
Settore
Industria
Telefono
-
Indirizzo
-
Compare XPH vs VTI, SPY, IVV, VB, QQQ
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XPH
State Street Spdr S P Pharmaceuticals Etf
|
68.01 | 229.97M | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
373.24 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
757.83 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
761.53 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
291.18 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
708.69 | 124.43B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Pharmaceuticals Etf Borsa (XPH) Ultime notizie
Better Healthcare ETF: Vanguard's VHT vs. State Street's Pharmaceuticals-Focused XPH - The Motley Fool
Better Healthcare ETF: Vanguard's VHT vs. State Street's Pharmaceuticals-Focused XPH - The Motley Fool
Which Healthcare ETF Is the Better Buy: Fidelity's Broad FHLC or State Street's Pharma-Focused XPH? - The Motley Fool
ETFs Investing in ANI Pharmaceuticals, Inc. Stocks - TradingView
Ditch These Historic ETF September Underperformers - Finviz
IBB Just Beat the S&P 500 by 22 Points in Three Months. Are You Late to the Party? - 24/7 Wall St.
State Street SPDR S&P Biotech ETF (XBI) rated B... - Pluang
XBI: Big Pharma Can Keep The 76% Rally Going (NYSEARCA:XBI) - Seeking Alpha
Healthcare Stocks Pick Up Steam as Investors Play Offense and Defense - Barron's
SPDR Series TrustState Street SPDR S&P Pharmaceuticals ETF Reports Earnings Results for the Full Year Ended June 30, 2026 - marketscreener.com
ETFs Investing in Ligand Pharmaceuticals Incorporated Stocks - TradingView
State Street SPDR S&P/ASX 200 Listed Property ETF Reports Daily NAV Update for September 2, 2026 - Kalkine Media
State Street SPDR S&P/ASX 200 ETF Announces Daily NAV and Fund Update for September 1, 2026 - Kalkine Media
Should You Invest in the State Street SPDR S&P Biotech ETF (XBI)? - Yahoo Finance
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now? - Eastern Progress
IHE vs. XBI: Pharma Stability or Biotech Growth -- Which Healthcare ETF Is the Better Buy? - AOL.com
Healthcare ETFs Are Looking Up: Here's Why - TradingView
ETFs Investing in Jazz Pharmaceuticals Public Limited Company Stocks - TradingView
Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI? - The Motley Fool
XPH vs PJP: Which Pharma ETF Offers Better Value - The Motley Fool
ETFs Investing in Arrowhead Pharmaceuticals, Inc. Stocks - TradingView
ETFs Investing in Prestige Consumer Healthcare Inc Stocks - TradingView
Biotechnology vs. Pharmaceuticals: What Are the Differences? - The Motley Fool
Better Healthcare ETF: State Street's Pharmaceuticals-Focused XPH vs. Invesco's S&P 500-Targeted RSPH - The Motley Fool
ETFs Investing in Viatris, Inc. Stocks - TradingView
iShares Global Healthcare ETF vs State Street SPDR Biotech ETF. Which Healthcare-Focused Fund Will Bring You Profits in 2026 and Beyond? - Yahoo Finance
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)? - Yahoo Finance
Is State Street SPDR S&P Telecom ETF (XTL) a Strong ETF Right Now? - Yahoo Finance
8 ETF Winners in the ‘Pay Me Now’ Trade - Barron's
Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Yahoo Finance
Is State Street SPDR S&P Semiconductor ETF (XSD) a Strong ETF Right Now? - finance.yahoo.com
Amneal Pharmaceuticals Inc (AMRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Viatris Inc (VTRS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Axsome Therapeutics Inc (AXSM) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
ANI Pharmaceuticals Inc (ANIP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Royalty Pharma PLC (RPRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Perrigo Company PLC (PRGO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Innoviva Inc (INVA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
EyePoint Pharmaceuticals Inc (EYPT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Harmony Biosciences Holdings Inc (HRMY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Madrigal Pharmaceuticals Inc (MDGL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Jazz Pharmaceuticals PLC (JAZZ) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Enliven Therapeutics Inc (ELVN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Harrow Inc (HROW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Liquidia Corp (LQDA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Supernus Pharmaceuticals Inc (SUPN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Ligand Pharmaceuticals Inc (LGND) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
Amphastar Pharmaceuticals Inc (AMPH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Nuvation Bio Inc (NUVB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Nektar Therapeutics (NKTR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
State Street SPDR S&P/ASX 200 ETF Posts $6.6 Billion Fund Value with 83.2 Million Units Outstanding - Kalkine
State Street Spdr S P Pharmaceuticals Etf Azioni (XPH) Dati Finanziari
Non sono disponibili dati finanziari per State Street Spdr S P Pharmaceuticals Etf (XPH). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.54%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):